tiprankstipranks
Trending News
More News >
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
Advertisement

Diaceutics (DXRX) Income Statement

Compare
10 Followers

Diaceutics Income Statement

Last quarter (Q4 2024), Diaceutics's total revenue was £19.84M, an increase of 65.65% from the same quarter last year. In Q4, Diaceutics's net income was £881.00K. See Diaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 32.16M£ 23.70M£ 19.50M£ 13.94M£ 12.70M
Gross Profit
£ 28.27M£ 19.71M£ 14.04M£ 10.57M£ 9.33M
Operating Expenses
£ 30.73M£ 22.72M£ 13.71M£ 10.25M£ 9.94M
Depreciation and Amortization
£ 4.63M£ 4.77M£ 3.01M£ 1.80M£ 809.00K
EBITDA
£ 2.77M£ 2.36M£ 3.61M£ 2.11M£ 178.00K
Operating Income
£ -2.46M£ -2.72M£ 331.00K£ 313.00K£ -610.00K
Other Income/Expenses
£ 547.00K£ 280.00K£ -97.00K£ -88.00K£ -72.00K
Pretax Income
£ -1.91M£ -2.44M£ 478.00K£ 293.00K£ -929.00K
Net Income
£ -1.70M£ -1.75M£ 724.00K£ 561.00K£ 263.00K
Per Share Metrics
Basic EPS
£ -0.02£ -0.02£ 0.01£ 0.01£ 0.00
Diluted EPS
£ -0.02£ -0.02£ 0.01£ 0.01£ 0.00
Weighted Average Shares Outstanding
84.45M 84.23M 84.15M 83.94M 77.53M
Weighted Average Shares Outstanding (Diluted)
84.45M 84.23M 86.09M 84.94M 77.83M
Currency in GBP

Diaceutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis